85.   At the informal session held on 19 June 2020, Members recognized the importance of IPrelated measures in response to COVID-19 and the unique role the TRIPS Council could play in this regard. In the complied list of IP measures in the context of COVID-19, China has confirmed two measures. 86.   The first one is the Notice on Time Limits for Handling Affairs Regarding Patents, Trademarks and Layout-Designs of Integrated Circuits under the impact of the COVID-19 pandemic, which has clarified and provided relief measures for parties exceeding the time limits for handling IP-related affairs. This Notice applies to all stakeholders across all countries and regions affected by the COVID19 pandemic. The purpose is to effectively protect their legitimate rights and interests. 87.   The second measure, the one my presentation focuses on, is the Information Sharing Platform for Patents on Pandemic Prevention against COVID-19, which has been developed by the China Patent Information Centre in February 2020 under the guidance of the China National Intellectual Property Administration (CNIPA). The Platform has provided professional and public welfare patent information assistance and services for stakeholders to carry on research related to COVID19 pandemic prevention and control. It has also made contributions to strengthening international cooperation and information sharing by means of providing comprehensive and technical patent information related to COVID-19. 88.   As you can see, this is the website and home page of the Platform (https://ncp.patentstar.cn/en). 89.   The Platform is built on the basis of the China Patent Research System (CPRS), which was also developed by the China Patent Information Centre. We selected more than 7000 patent documents in the key areas of technological innovation related to "fighting against COVID-19" from the database of CPRS. According to their technical relevancy and degree of importance, these patent documents are divided into nine first-level branches, 35 second-level branches and 78 third-level branches. They cover the wide spectrum of technical fields including treatment medicines, prophylactic medicines, detection and diagnosis reagents, medical instruments, etc. 90.   When you access this Platform, you will find its bilingual interfaces: one is Chinese and the other is English. Take this document as an example. The Platform provides detailed information on the patent documents, such as its bibliographic data, full-text, claims, specification, and legal status. It is also possible to download the file. 91.   The Platform integrates functions of retrieval, online translation, communication feedback, etc. The database affiliated to the Platform has been updated regularly. The Platform can be accessed for free without prior registration. The statistics show that, as of 26 July 2020, the Platform has received visitors from more than 60 countries and regions with 238,148 hits in total. 92.   If you have any further questions or would like to get more information about the Platform, please contact us through the contact information shown on the screen (email:fuwubu@cnpat.com.cn, phone: +86-10-61073090).